Discover how pharmaceutical titans maintain their monopolies through a secretive process known as 'pay-for-delay' settlements. This exposé dives into the legal loopholes that allow brand-name drug companies to pay generic manufacturers millions of dollars to keep cheaper alternatives off the shelves. While these agreements are framed as routine legal settlements, they effectively prevent competition and force patients to pay higher prices for life-saving treatments. We explore the massive economic impact of these deals, which the Federal Trade Commission identifies as a primary driver of rising healthcare costs. Learn how the system prioritizes corporate profit margins over patient access to affordable care. This video reveals the mechanism behind artificial price inflation in the medical industry and why your prescriptions remain so expensive. Understanding these hidden wealth transfers is the first step toward seeing the true mechanics of modern economic inequality.
